ObsEva appoints Brian O’Callaghan as Chief Executive Officer
November 09, 2020 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – November 9, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve...